Skip to content
Search

Latest Stories

UK Covid-19 death toll hits 51,766

The UK Covid-19 death toll hit 51,766 on Tuesday (June 9), according to a Reuters tally of official data sources that confirmed the country's place as one of the worst hit in the world.

The Reuters tally comprises fatalities where Covid-19 was mentioned on death certificates in England, Wales and Northern Ireland up to May 29, and up to May 31 in Scotland. It also includes more recent hospital deaths.


Unlike the lower death toll published daily by the government, the death certificate figures include suspected cases.

The Covid-19 epidemic in care homes is coming under control, Health Secretary Matt Hancock said on Monday (June 8) after announcing that all remaining adult care homes would have access to testing for residents and staff.

The announcement means that working-age care homes will have access to a full Covid-19 testing service, in addition to care homes for the elderly, which had been prioritised previously.

"With all the measures that we've put in place over the last few months... it is clear that the epidemic in care homes is coming under control," Hancock said at a daily news conference, citing a fall in the number of new care homes reporting an outbreak in latest weekly figures.

"Even those care homes where there are cases have very strong infection control procedures in place," he added.

Meanwhile, British drugmaker AstraZeneca on Tuesday said it expects to move two Covid-19 antibody based therapies it has licensed from US researchers into clinical studies in the next two months as it ramps up efforts to help combat the pandemic.

The company, which has a potential coronavirus vaccine in its pipeline, said it has agreed terms with the Defense Advanced Research Projects Agency and the Biomedical Advanced Research and Development Authority to back its project to develop a monoclonal antibody treatment against the virus.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less